Gemcitabine hydrochloride
| | 122111-03-9 Basic information More.. |
| Product Name: | Gemcitabine hydrochloride | | Synonyms: | 2’,2’-difluorodeoxycytidinemonohydrochloride;2’-deoxy-2’,2’-difluorocytidinemonohydrochloride;2’-deoxy-2’,2’-difluoro-cytidinmonohydrochloride;ly188011;ly188011hydrochloride;2',2'-DIFLUORO-2'-DEOXYCYTIDINE;2'-DEOXY-2',2'-DIFLUOROCYTIDINE;2'-DEOXY-2',2'-DIFLUOROCYTIDINE HYDROCHLORIDE | | CAS: | 122111-03-9 | | MF: | C9H12ClF2N3O4 | | MW: | 299.66 | | EINECS: | 601-823-3 | | Mol File: | 122111-03-9.mol |  |
Use
Gemcitabine hydrochloride is a synthetic novel difluoro nucleoside drug that is anti-metabolic and antineoplastic, suitable for the treatment of inoperable advanced or metastatic pancreatic cancer and the treatment of locally advanced or metastatic non-small cell lung cancer, and the treatment for mid-term and advanced non-small cell lung cancer, non-small cell lung cancer, pancreatic cancer, bladder cancer, breast cancer and other solid tumors.
|
|
122111-03-9
Recommend Suppliers |
|
| Tag:
122111-03-9
|